Tag: iFuse

SI-Bone announces publication of two-year iMIA randomised controlled trial results

Two-year results of a randomised controlled trial, published in the Journal of Bone and Joint Surgery, suggest that minimally invasive sacroiliac joint arthrodesis with triangular...
IFuse 3D plus autograft bone growth

“Significantly more bone infiltration” with 3D-printed triangular sacroiliac joint fusion implants

The popularity of sacroiliac joint fusion has grown rapidly over the past five years, with SI-Bone’s Ifuse device leading the market. Recently approved by...

One-year data reveal superior pain improvements for SI-Bone Ifuse

One-year results from the IMIA (Ifuse Implant System Minimally Invasive Arthrodesis) randomised controlled trial have shown better pain and disability improvements for SI-Bone’s Ifuse...

Highmark to cover non-Ifuse sacroiliac joint fusion systems

Highmark, the USA’s fourth-largest Blue Cross and Blue Shield-affiliated insurer, has expanded positive coverage of sacroiliac joint fusion devices. All devices cleared by the...

SI-Bone launches new 3D-printed porous Ifuse-3D sacroiliac joint fusion device

SI-Bone has launched its new Ifuse-3D implant in the USA following regulatory clearance by the US Food and Drug Administration. The new titanium device...
SI-Bone Ifuse

US military’s Tricare health care programme offers minimally invasive sacroiliac joint...

Tricare has established a written coverage policy for minimally invasive sacroiliac joint fusion surgery. Tricare is a regionally-managed US healthcare programme for active duty...
SI-Bone Ifuse

Si-Bone Ifuse sacroiliac joint fusion procedure reaches 25,000 milestone

The Si-Bone Ifuse minimally invasive sacroiliac joint fusion implant system has been used in more than 25,000 procedures worldwide, according to a company release....

Six-year positive results published on Si-Bone iFuse

Si-Bone has announced the publication of a six-year study comparing the company’s Ifuse implant to both conservative management and radiofrequency denervation. The long-term study...

Decortication and bone-grafting may “contribute to earlier fusion” following sacroiliac joint...

Sacroiliac joint fusion has progressed markedly over the past five years. Positive results—the majority involving SI-Bone’s Ifuse device—have been reported in a growing number...
SI-Bone Ifuse

Sacroiliac joint fixation with screws leads to more revision than fusion...

A single-centre retrospective study of patients who had undergone sacroiliac joint fusion has compared revision rates between those who received fusion via titanium triangular...
SI-Bone Ifuse

SI-Bone submits INSITE data to Yale University Open Data Access programme

SI-Bone has submitted INSITE (Investigation of Sacroiliac Fusion Treatment) two-year randomised controlled trial data to Yale University's Open Data Access (YODA) programme. INSITE is a...

Two-year INSITE results show positive outcomes for SI-Bone iFuse system

SI-Bone has announced the publication of two-year results from INSITE (Investigation of Sacroiliac Fusion Treatment) a landmark prospective, multicentre, randomised controlled trial of minimally...

Investigating sacroiliac joint fusion surgery

Sacroiliac joint fusion surgery has grown in popularity over the past five years. Whilst procedure rates are still relatively low, many physicians are convinced...